Bio-Techne
TECH
#1479
Rank
C$16.78 B
Marketcap
$105.65
Share price
-0.50%
Change (1 day)
30.55%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

P/S ratio for Bio-Techne (TECH)

P/S ratio as of November 2024 (TTM): 10.4

According to Bio-Techne's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.84. At the end of 2024 the company had a P/S ratio of 9.74.

P/S ratio history for Bio-Techne from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20249.74-8.6%
202310.7-8.26%
202211.6-41.16%
202119.728.67%
202015.335.99%
201911.340.86%
20188.01-1.07%
20178.1011.46%
20167.260.94%
20157.20-14.26%
20148.39-20.67%
201310.631.29%
20128.06-2.18%
20118.24-7.85%
20108.94-7.32%
20099.657.08%
20089.01-16.95%
200710.85.15%
200610.3-9.54%
200511.419.31%
20049.56-5.57%
200310.117.54%
20028.61-31.35%
200112.5

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
5.00-52.06%๐Ÿ‡บ๐Ÿ‡ธ USA
3.95-62.16%๐Ÿ‡บ๐Ÿ‡ธ USA
3.39-67.50%๐Ÿ‡บ๐Ÿ‡ธ USA
8.89-14.81%๐Ÿ‡บ๐Ÿ‡ธ USA
5.05-51.63%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
3.68-64.68%๐Ÿ‡บ๐Ÿ‡ธ USA
1.86-82.18%๐Ÿ‡บ๐Ÿ‡ธ USA